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ABSTRACT
Noninvasive Measurement of Arterial Compliance with a Blood Pressure Cuff using a Surrogate
Arm Bench Top Model for Oscilloemtric Use
Shane Wilsey

A surrogate arm model was created that is capable of being used for oscillometry. This
model is capable of being used as a bench top model for blood pressure cuff devices. The arm
consists of endplates and internal supports that are 3D printed with ABS, a silicone rubber outer
sleeve, and interchangeable arteries made from two silicone rubber strips glued together at the
edges. The interchangeable arteries have varying compliances that can be used as different inputs
for oscillometric testing. A process was established to measure the artery compliances with a
curve fit correlation of 0.95. However, testing revealed that this artery compliance relationship
might not be an accurate representation of the artery compliance while it is in the surrogate arm
system. A blood pressure cuff was also used with the surrogate arm model to measure changes in
artery volume. Testing with the surrogate arm revealed a blood pressure cuff was capable of
measuring artery volume changes of 2mL to 8mL consistently within 3.28% error. Volume
changes of 1mL were unable to be repeatable measured accurately with a blood pressure cuff.
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Chapter 1
INTRODUCTION
1.1 Ischemic Heart Disease and Atherosclerosis
Cardiovascular diseases are continually the leading cause of death across the globe.
Cardiovascular related deaths make up an estimated 31% of all deaths each year with roughly
85% of those deaths resulting from heart attack or stroke [1]. Heart attack and ischemic stroke,
the most common type of stroke, result from an occluded blood vessel blocking the flow of
oxygen rich blood cells to either the brain or heart, causing tissue death. Nearly all occlusions in
vessels occur due to embolism or chronic buildup of plaque inside the artery. These events are
both linked with the cardiovascular disease atherosclerosis, which is associated with numerous
health complications and a significant increase in risks for life ending cardiovascular events.
Atherosclerotic plaque buildup is the result of mostly preventable factors, such as diet, activity
level and cigarette smoking. Other factors leading to atherosclerosis include high blood pressure
and diabetes. Buildup can occur due to increased levels of cholesterol in the bloodstream or
damage to the blood vessel endothelium lining due to an injury, infection, or high pressure stress
on vessel walls [2].
Not only does atherosclerosis affect a blood vessel by occluding it and reducing blood
flow, but it also stiffens the vessel and inhibits proper function. The stiffened vessels become
unable to respond adequately to both exogenous and endogenous signals to dilate and contract
properly. This prevents hemodynamic maintenance and stability, resulting in increased blood
pressure and pulse wave velocity. In addition to increasing risk of coronary artery disease
progression, atherosclerosis contributes to other cardiovascular complications such as cerebral or
renal aneurysm formation, peripheral artery disease, and increased damaging stress across all
blood vessels leading to further plaque formation. Also, atherosclerotic plaque can form in all
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blood vessels, so plaque rupture can occur anywhere in the body. For these reasons, the overall
health and wellbeing of a patient with atherosclerosis can degrade quickly if not identified and
treated early. Most treatments for atherosclerosis typically only serve to prevent further plaque
development through drugs and lifestyle changes, or to “push” the plaque out of the way
surgically with angioplasty. However, this is only a temporary solution for reducing the
immediate risk of heart attack or stroke.
1.2 Subclinical Atherosclerosis and Endothelial Dysfunction
The endothelium plays a major role in the function of the whole cardiovascular system by
secreting a number of different factors. Although only one layer thick, the endothelium
continuously monitors its environment and responds to specific hemodynamic and humoral
signals using endothelium specific membrane receptors. Under specific physical or chemical
stimuli, the endothelium will synthesize and release a variety of substances either inward into the
blood stream or outward into other blood vessel layers. When a blood vessel is damaged or
experiences stress due to high pressure, an inflammatory response causes the endothelium to
release factors influencing coagulation, fibrinolysis, leucocyte adherence and platelet interactions
into the bloodstream. Vasodilators, like nitric oxide (NO), and vasoconstrictors, such as
endothelin-1(ET-1) and angiotensin II (Ang II), are also secreted from the endothelium into the
surrounding smooth muscle cells to control a dynamic, geometric response to blood pressure and
blood flow [3, 4].
Even when no observable signs of atherosclerosis are present, endothelial dysfunction
can still be occurring. Endothelial dysfunction (ED) is the inability of a blood vessel’s
endothelium to produce the proper amounts of relaxing agents and other secretory factors
necessary for a blood vessel’s functioning. This results in inadequate maintenance of vascular
homeostasis and hemodynamics [3]. Areas of ED show higher levels of vasoconstricting factors
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and lower levels of vasodilating factors, contributing to the development and progression of
atherosclerosis [5]. Blood vessel exhibiting endothelial dysfunction also show increased levels of
coagulation factors, making them more susceptible to clot formation. ED precedes plaque
formation, and typically results from the same factors that cause cardiovascular disease
progression (diet, activity level, chronic smoking, diabetes, etc.…). It is a predecessor and major
predictor of other subsequent cardiovascular related diseases associated with pathological
conditions that effect vasoconstriction, thrombosis, and inflammatory state [6, 7]. When
endothelial dysfunction occurs, it can elicit a wide range of anatomic and physiologic changes
throughout different parts of the body. First and foremost, it decreases the compliance response
(pressure driven volume change) of the blood vessel, resulting in a range of downstream
measured effects depending on the location of a stimulus like reactive hyperemia or cold pressor.
For example, decreased compliance of the aorta reduces the dampening effect the aorta has on
systolic blood flow that is ejected from the heart, referred to as the Windkessel effect [8]. A
portion of the pressure waveform after the dicrotic notch represents this effect. This reduced
dampening, in turn, leads to adverse effects on other parts of the body such as increased
vulnerability of microcirculation vessels in vital organs like the kidneys and the brain [9].
Endothelial dysfunction is also linked to non-cardiovascular disease progression, such as
rheumatoid arthritis, due to it causing insufficient transport and exchange of oxygen and other
necessary nutrients in microvascular structures [10].
Endothelial dysfunction is the first step in a progression of events that, most of the time,
lead to the onset of the pathogenesis of many irreversible diseases like atherosclerosis and
hypertension. Fortunately, pathological development of these diseases can be greatly slowed
down or prevented completely though maintenance of the endothelium and reduction of
endothelial dysfunction. Because endothelial dysfunction is a reversible condition [10], early
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identification and treatment of ED is of paramount importance for preventing the development of
many diseases.
1.3 Current Technologies for Measuring Endothelial Health
Measuring endothelial heath can be utilized to detect endothelial dysfunction which can
provide evidence to make predictions of future cardiovascular events [6]. Measurement of
endothelial heath is done by measuring the functional endothelial response to specific stimuli.
Methods typically revolve around measuring flow mediated dilation (FMD). FMD is the selfregulating dilation and constriction response that blood vessels exhibit in response to changes in
blood flow, pressure, and shear [11]. The level of dilation or constriction that occurs is indicative
of the overall vascular system health. It can be measured either invasively or noninvasively in a
range of different ways. These measurements can either be through visual measurement with
imaging tools such as intra-cardiac echo, an invasive method, or brachial artery ultrasound.
Imaging methods are beneficial because they allow for the direct visualization of the FMD
response, but the results are not always reliable due to difficulty of making measurements on the
images and no standardization of baseline measurements for patients.
Because of this, instruments that can detect physical measurements from mechanical
changes have become more widely used. These include technologies such as plethysmography,
tonometry, and oscillometry that can non-invasively measure flow mediated dilation. Tonometry
and plethysmography are both used to measure displacement of blood vessels due to volume
change at each pulse whereas oscillometry is used to indirectly measure pressure changes
occurring inside the blood vessel. Although these technologies have shown some success in
measuring endothelial health for endothelial dysfunction detection [12] [13], they are not capable
of making measurements with enough confidence to diagnose endothelial dysfunction by
themselves. It is proposed that a combination of these methods would be capable of doing so.
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1.4 Methodology of Study
Cordex Systems Inc. is a company seeking FDA clearance of a new endothelial function
measurement device, the Cordex SmartCuff. This device utilizes multiple endothelial dysfunction
detection methods, such as segmental cuff plethysmography and oscillometry, to offer a reliable,
accurate and repeatable method of measuring patient endothelial health. Cordex Systems claims
that their SmartCuff device has segmental plethysmography capabilities that can accurately
measure brachial artery compliance in the brachial artery as part of its assessment of endothelial
health. It does this through a new process called calibrated cuff plethysmography, where a blood
pressure cuff is used to measure the brachial artery volume response change, instead of using a
tonometer.
This study aims to show the capabilities of a blood pressure cuff to be able to accurately
measure compliance response of an elastic tube with steady, oscillatory flow conditions. This will
be done using a second generation surrogate arm in vitro model (SAIVM) that was derived from a
design created by Dr. Yong and Dr. Geddes in 1990 [14]. The system will consist of an elevated
water reservoir and diaphragm pump. The surrogate arm consists of 3D printed endplates and
internal supports enclosed by a silicone rubber sleeve and filled with water. The surrogate arteries
will consist of two flat silicone strips that are epoxied together.
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Chapter 2
THEORY REVIEW
2.1 Vascular Mechanics and Hemodynamics
The cardiovascular system consists of a complex arrangement of blood vessels that act as
a transport system for oxygen and many other nutrients throughout the whole body. Blood vessels
are categorized into three main categories: arteries which carry blood away from the heart, veins
which carry blood toward the heart, and capillaries where oxygen is exchanged from red blood
cells into tissues. Arteries and veins can be further classified into arterioles and venules based on
their size and locations. [15] All blood vessels have the same basic structure with their walls
composed of three distinct layers. The tunica intima is the inner most layer and consists of an
endothelial cell layer surrounded by elastic connective tissue. The middle layer, called the tunica
media, is composed primarily of smooth muscle. The tunica media provides structural stability
and allows for dilation and contraction of the vessel. The outer most layer is the tunica externa,
also known as the tunica adventitia, which is connective tissue composed of primarily elastin and
collagen fibers [16]. Differences in the structure between veins and arteries, which can be seen in
Figure 1, allow for differing functions in the circulatory system.
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Figure 1. Structure of blood vessels [15]
The structure of arteries provides the necessary mechanical function to control blood flow
and pressure waveforms. Arteries are viscoelastic, meaning they contain both viscous and elastic
components in their structure. Elastin is contained in the extracellular matrix of artery makeup
and gives arteries their elastic, shape retaining properties. Elastin is also responsible for most of
the structural support of arteries during low stresses [17]. Collagen is the primary component that
provides arteries with viscous properties and more rigid support at high stresses. The
collagen/elastin ratio is crucial in providing adequate mechanical function of arteries in all parts
of the body. Unfortutanly, arteries develop to full maturity at a young age with a set amount of
elastin available in their structure. Throughout life, elastin becomes less abundant in arteries,
increasing the collagen/elastin ratio and contributing to gradual stiffening of arteries with age
[13].
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A healthy endothelium is essential for the proper function of the cardiovascular system to
act as a transport network for the body. Along with ensuring adequate transport of nutrients,
oxygen, and signaling molecules throughout the body, the endothelium serves to help regulate
host defense, act as a monolayer for nutrient exchange and molecular signaling, prevent adhesion
of immune cells and infiltrative monocytes that can lead to atherosclerosis, and control vascular
tone through the release of vasodilators and vasoconstrictors [6]. When the endothelium is
inhibited from functioning properly, typically from the known risk factors that cause
cardiovascular disease, endothelial dysfunction can occur that can lead to further complications
such as atherosclerosis.
2.1.1 Atherogenesis
Atherosclerosis is a disorder that results in adhesion of monocytes and lymphocytes to
the endothelial wall of blood vessels [18]. High plasma levels of low density lipoproteins (LDLs)
and decreased plasma levels of high density lipoproteins (HDLs), along with occurring
endothelial dysfunction tend to be linked with increased rate of atherogenesis. Excess LDLs will
become modified into oxidized LDLs (oxLDLs). At signs of damage to the endothelium, the
inflammatory response recruits inflammatory cells like monocytes and lymphocytes to the area.
Local chemokines in the inflammation area cause monocytes to mature into macrophages that
possess the necessary scavenger receptors, such as CD36 and SR-A, to ingest modified lipids
through receptor-mediated endocytosis. Oxidized LDLs are not digestible by macrophages, so the
process results in the formation of foam cells. These foam cells then exit the bloodstream and
embed themselves into the subendothelial space [19]. This creates the formation of fibrous
plaques. As lesions progress and fibrous plaques grow, growth factors induce smooth muscle
cells to migrate and proliferate throughout the intima. This reduces the stability of the blood
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vessels at the sites of plaque formation that can result in plaque rupture and thrombosis (Figure 2)
[20].

Figure 2. Plague Development and Atherogenesis [20]
2.1.2 Endothelial Dysfunction
Endothelial dysfunction (ED) is the first clinical correlate of atherosclerosis identification
[21]. It is a key element in the development of atherosclerosis and precedes any morphological
plaque development. Inflammation conditions are involved with the progression of ED [22].
Cardiovascular risk factors, such as hypocholesterolemia or smoking, lead to the vascular tissue
to experience oxidative stress which induces ED. These factors result in reduced bioavailability of
endothelium derived vasodilators, most important being nitrogen oxide (NO). NO, along with
being a key vasodilator for maintaining hemostasis, acts to keep vascular smooth muscle in a nonproliferative state and inhibits platelet and white blood cell activation in the bloodstream [4]. NO
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also negates the effects of contracting factor, therefore ED also results in an increase of
vasoconstrictors like angiotensin II (A-II) and endothelin I (ET-I). Reduced availability of NO
and increased amounts of A-II and ET-I lead to a stiff and unhealthy blood vessel that is more
susceptible to endothelia damage. The inflammatory response to diseased and damaged vessels
initiates atherogenesis.
2.1.3 Arterial Compliance and Distensibility
Compliance describes volumetric change of elastic structures. By definition, compliance
is the change in volume due to the change in pressure (

𝑑𝑉
𝑑𝑃

). For arteries, this means that arterial

compliances describe the change in artery volume due to changes in blood pressure. Distensibility
is the normalized measurement of compliance. While compliance is the change in volume from
pressure change, distensibility is the compliance per unit volume. Arterial compliance can also be
described in a 2 dimensional space as the change in cross sectional area of a blood vessel to
changing blood pressure [23]. Due to the elastic nature of arteries, the compliance curve follows a
nonlinear relationship at different pressures (Figure 3). When the transmural pressure is positive,
the artery wall stretches and the cross sectional areal increases. When the transmural pressure is
negative, the wall stretch becomes negligible and the wall collapses on itself. The wall will
collapse to an elliptical shape until it becomes completely flat [24]. Reduced arterial compliance
is an indicator that ED is present.
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Figure 3. Nonlinear Artery Compliance and Transmural Pressure Relationship [24]
2.2 Endothelial Assessment by Flow Mediated Dilation
Endothelial health is assessed my measuring blood vessel flow mediated vasodilation
(FMD) response. Blood vessels respond to specific stimuli in order to self-regulate tone and
maintain hemostasis. Increases in blood flow, more specifically increases in shear stress, lead to a
number of different cell signaling pathways to release necessary relaxing factors, such as nitric
oxide, resulting in vasodilation. Blood flow induced shear stress on the endothelial wall is one of
the most significant contributors to endothelial function [22].
Flow mediated dilation is often measured in response to reactive hyperemia. In reactive
hyperemia, the blood vessel is occluded and deprived of oxygen. When the blood flow returns
and an increased shear force is exerted on the blood vessel wall, the blood vessel dilates to a
larger diameter than what it typically is under normal blood flow conditions. The amount of
dilation after reactive hyperemia compared to the blood vessel’s baseline diameter give
information about the health of the endothelium.
2.2.1 Imaging Techniques
Imaging methods can be used to evaluate an exposure response to FMD. They involve
obtaining the baseline diameters of blood vessels and measuring their amount of dilation or
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constriction that occurs. Invasive techniques typically consist of intra-arterial administration of
NO releasing compounds and measuring the dynamic blood vessel response via doppler wires or
imaging catheters [25]. A properly functioning artery will respond by dilating. Conversely,
vasoconstriction after injection indicates an artery experiencing ED [4]. Although this is an
accurate and repeatable technique for identifying blood vessel specific ED, it is not practical for
clinical diagnostic use due to its invasive nature and subsequent risks for the patient. Therefore,
FMD is more commonly assessed through noninvasive techniques.
One way in which this is done is by using a noninvasive imaging technique, typically
ultrasound, to monitor and measure the response of reactive hyperemia [25]. This is most
commonly performed on the brachial artery, referred to as brachial artery ultrasound (BAUS),
because the brachial artery dysfunction is an important indicator of systemic endothelial
dysfunction [26]. Also, the brachial artery function and health shows a close relationship to the
functional ability of the coronary arteries [27]. In brachial ultrasound, a sphygmomanometer cuff
(blood pressure cuff) is inflated beyond systolic pressure and maintained for 5 minutes to induce
hyperemia in the blood vessel. Upon release of the pressure in the cuff, blood flow returns, and
the vessels respond accordingly through the release of dilating factors such as NO, making FMD
an indirect measurement of NO production [11]. However, the reactive hyperemia responses vary
greatly in individuals due to non ED related reasons, such as food intake that day or day of
activity level. This makes standardization of endothelial measurement from noninvasive FMD
difficult. It also lacks reproducibility in results, making it unreliable for diagnostic use solely on
its own.
2.2.2 Plethysmography and Tonometry
Endothelial function can also be assessed by analyzing the pressure induced volume
change of a blood vessel to determine arterial compliance. This is an idea called
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plethysmography, defined as measuring volume changes in different parts of the body. One way
this is done is with a tool called a tonometer. Tonometers measure changes in arterial pressure
which can be used to determine the volume change within the artery. Measuring arterial
waveforms dates to 1860 with the invention of the sphygmograph. This device mechanically
recorded waveforms of the peripheral arteries in the wrist with a lever or needle.
Arterial tonometers today are all descendants of this device and revolve around
measuring volume change from blood pressure pulses. One such tonometer is a flexible
diaphragm tonometer, as described in Drzewiecki 1995 [14]. This detects pressure and volume
changes within the brachial artery using a conductive saline solution contained within a handheld
device with a flat flexible diaphragm on one side. The device utilizes impedance
plethysmography to sense displacement of the saline fluid, due to a blood pulse, when the device
is held to the patient’s brachial artery. This device was already shown to be able to determine
blood vessel compliance [12], but due to variability device placement during use, the results of
this test are not always repeatable.
A more common tonometry method is peripheral artery tonometry. This method
measures the pulse volume change in the fingertip, typically in response to reactive hyperemia.
This indicates the microvascular function which has been shown to correlate both with total
endothelial function as well as hemodynamic function of a patient. Results vary based on the
tightness of the device, and the fact that atherosclerotic related conditions may have variable
effects on peripheral artery tonometry make this also unreliable [28]. This makes peripheral artery
tonometry alone a non-viable method of endothelial dysfunction detection.
Cuff plethysmography is a technique that uses a blood pressure cuff to measure changes
in artery diameters in the upper arm region where the cuff covers. It is an all-inclusive technique
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that measures all arteries in the cuff. Cuff plethysmography responds most fully to the largest
vessels contained within the cuff, the brachial artery.
2.2.3 Oscillometry
Oscillometry is another method that can be used to detect endothelial dysfunction by
measuring the pressure of a blood vessel during the cardiac cycle. This is done using a
sphygmomanometer that surrounds the patient’s arm and measures pressure change during each
pulse rather than a single flat surface that measures displacement, as is the case in tonometry. In
the cardiac cycle, arterial volume increases during systole, causing cuff volume to decrease and
cuff pressure to increase. During diastole, arterial volume decreases, increasing the cuff volume
and decreasing the cuff pressure. This creates an oscillatory pressure signal in the blood pressure
cuff that can be used to determine the arterial flow waveform, because oscillometric data of
pressure waveforms closely resemble flow waveforms [29]. Oscillometry for endothelial
dysfunction detection is typically done to measure the reactive hyperemia response. The blood
pressure cuff is inflated to exert a force beyond systolic pressure. This pressure is then maintained
in the cuff for 5 minutes to induce hyperemia in the brachial artery. After this, the cuff pressure is
slowly released while pressure waveforms transmitted from the arterial blood flow measured in
the cuff create a decaying, oscillatory cuff pressure vs time function. This signal is then further
processed and analyzed to assess the endothelial function of the brachial artery which can be
related to the rest of the cardiovascular system to make predictions of future cardiovascular
events.
To calculate the pressure gradient in tubes, either Poiseuille’s law or the theory of Wang
and Tarbell is used. Poiseuille’s law is used for calculating the pressure gradient of steady flow in
a rigid straight tube. This method cannot be used for application of pressure gradient in a human
artery due to the elastic nature of blood vessels and the oscillatory flow that they experience. So,
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instead, the theory of Wang and Tarbell which was established in 1992 and verified in 1995, must
be used [30]. This theory takes into account how wall motion of elastic tubes creates a nonlinear
convective acceleration. An induced mean pressure gradient is then needed to balance the
convective acceleration. The theory of Wang and Tarbell is a correction to Womersley solution
that was established in 1995, which defines the amplitude of the pressure gradient caused by
sinusoidal flow of a Newtonian fluid in a rigid, straight tube.
2.3 Blood Pressure Cuff Mechanics
In 1993, the mechanics of an occluding arm cuff were determined in a study published by
Dr. Drzewiecki and Bansal [31]. Prior to this, the blood pressure cuff had not been fully described
in engineering terms although it was a common medical instrument for assessing blood pressure
that had been used for years. In the experiment, two calibrated syringes were used with a blood
pressure cuff and a balloon contained within a glass cylinder (Figure 4). One syringe controlled
air volume in the blood pressure cuff, and the other controlled water volume in balloon. A
manometer then recorded the corresponding pressure in the cuff.

Figure 4. Experimental Setup for Determining Cuff Characteristics [31]
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In the experiment, the cuff was first emptied then filled with increments of known air
volume. At each increment, the balloon was filled with 1mL increments of water for up to 5mL of
water and the resulting pressure was recorded in the cuff. From these measurements, two plots
were able to be generated: one of cuff pressure vs cuff air volume and another plot of cuff
pressure vs water volume. Taking the derivative of the cuff pressure vs cuff air volume then
allowed the cuff distensibility (dP/dV) plot to be generated. Figure 5 displays the graphical results
taken from this experiment and Figure 6 displays the distensibility curve of the cuff that were able
to be generated.

Figure 5. Plots Generated from cuff mechanics study. Cuff Pressure vs Cuff Air Volume (left)
Cuff Pressure vs Water Volume (right) [31]
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Figure 6. Cuff Distensibility Curve from Cuff Mechanics Study [31]
In this article, a mathematical model for using a cuff as a plethysmograph for making arm
volume measurements is presented. It is done by determining the cuff pressure sensitivity to arm
𝑑𝑃

𝑑𝑃

𝑖

𝑖

[(𝑃+𝑑𝑃)−(𝑃−𝑑𝑃)]

volume change (𝑑𝑉 ), represented by the equation 𝑑𝑉 = [𝑉 (𝑃+𝑑𝑃)−𝑉 (𝑃−𝑑𝑃)] ,where P is the initial
𝑖

𝑖

cuff pressure, dP is the change in cuff pressure, and 𝑉𝑖 is the arm volume.
2.5 Bench Top Model Testing
For medical devices to receive either market approval or market clearance, nonclinical
and clinical testing must be completed. Nonclinical testing can vary in objective and scope and
typically fall into one of three different categories, bench top model testing, in vitro model
testing, and in vivo model testing. Bench top models refer to models that have no biological
components and are tested “on the bench”. In vitro models consist of models also tested on a
bench but involve some sort of physiological component or replication. In vivo models then refer
to testing of a medical device or component of a device in an animal. Sufficient preclinical testing
must be completed in order to show (or sometimes imply) some level of safety and efficacy of a
device in order for an investigational device exemption (IDE) to be received which allows for the
device to be used in clinical testing. Specifics of how these preclinical tests are carried out can
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vary based on the type of device and whether it is seeking market approval (PMA) or market
clearance (510(k)) from the FDA. The FDA does not explicitly describe how preclinical tests
must be carried out, but it supplies guidance documents to help create guidelines for what type of
information should be included in reports, summaries, and protocols when establishing a
preclinical test. There are guidance documents specific to bench testing, in vitro testing, and in
vivo testing.
The FDA guidance document titled “Recommended Content and Format of Non-Clinical
Bench Performance Testing Information in Premarket Submissions” docket number FDA-2018D-1329 outlines the relevant information and format of non-clinical bench tests for submission to
the FDA. The guidance document pertains to bench testing of mechanical or biological
engineering performance of the device and is current as of the most recent revision from
December 20, 2019. Bench top tests submitted to the FDA for device approval or device
clearance must also follow good laboratory practices (GLPs). Before a test is conducted, the test
protocol, sample size, pass/fail criteria, and plan for data analysis all need to be established and
documented. These must all be reviewed and approved by the primary investigator (PI) of the
study. Repetitive tasks and any system calibration protocols must also be documented and
approved. Any protocol deviations made during the study must be taken note of and approved by
the PI. Reported results of the study should include all data collected and data analysis, including
any outlying points. A final report will include all of the above mentioned information along with
a description of the test being performed, the goal of the test being conducted, and conclusions
and discussion section [32].
2.4 First Generation Surrogate Arm In Vitro Model
In 1990, Dr. Yong and Dr. Geddes developed a model, which they called a “surrogate
arm in vitro model,” that was able to act as a bench top model for evaluating the accuracy of
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blood pressure cuff devices. This model consisted of a raised water reservoir that can be adjusted
to create a diastolic pressure that was connected to a water filled balloon that could be
compressed using an air source and solenoid oscillator to act as a diaphragm pump (Figure 7).
The arm itself consisted of a 25cm long and 30cm circumference Silastic sleeve that was clamped
to two circular endplates (Figure 8). The arm was filled with water and air and contained an
artificial artery which was made of two Silastic strips cemented together on the edges. This
allowed it to collapse and open with changing internal pressures (Figure 9). The compliance of
the arm was controlled and could be varied using different ratios water and air. The compliance
of the arm, artificial artery, and blood pressure cuff was found to be defined by the relationship
1
𝐶𝑐𝑎

1

1

= 𝐶 + 𝐶 where Cca is the compliance of the entire cuff-arm system, Ca is the compliance of
𝑎

𝑐

the artery, and Cc is the compliance of the cuff alone.

Figure 7. Yong and Geddes Surrogate Arm Model System Design [14]
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Figure 8. Yong and Geddes Surrogate Arm Design [14]

`
Figure 9. Yong and Geddes Surrogate Artery Design [14]
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Chapter 3
METHODS
3.1 Second Generation Surrogate Arm In Vitro Model System
The second generation surrogate arm model design was based on the Yong and Geddes
surrogate arm model as described in Chapter 2 and modified to support oscillometric use. The
design was intended to be low cost and have different testable artery compliances. The main
components of the model include the arm skeleton, the outer arm sleeve, and the arteries. The arm
skeleton was designed using Fusion 360 and fabricated though 3D printing. It consists of two
different endplates and internal support rods. Sleeves were made from silicone rubber sheets and
molded silicone rubber. The arteries consisted of two 1mm thick silicone rubber strips glued
together at the edges.
3.2 Arm Skeleton Design and Fabrication
The surrogate arm model went through multiple different design iterations prior to
completing the study. As each design iteration was built, issues were identified that led to design
changes. Most design changes made were necessary in order to achieve an airtight seal of the
arm. Other changes were done in order to reduce error during experimentation. Each design
iteration is laid out and described in the following sections along with the reasoning for each
change.
3.2.1 Skeleton Design Iteration 1
The first iteration of the skeleton consisted of a 1.25in thick cylinder with an outer
diameter of 4.25in and an inner diameter of 4in. The sleeve was intended to sit over the small
diameter portion while the larger diameter sits on the surrogate arm stand. The diameter of the
center hole for the artery was 1/8in in order to replicate the diameter of a brachial artery.
Surrounding the center hole is another hole of 1in diameter and 1/2in deep. This hole was created
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to increase the compliant area of the artery. Each endplate also had 3 equally spaced 1/2in x 1/2in
square holes for the support beams. On one endplate, two 1/2in holes were added as fill and vent
holes. The design of the arm can be viewed in Figure 10 and Figure 11. The endplates, support
beams, and arm stand were all 3D printed using PLA.

Figure 10. Endplates for the First Iteration of the Surrogate Arm Model.

Figure 11. First Iteration Arm Skeleton Design on Arm Stand.
Luer locks were the original design choice for the arm / artery fittings. This choice was
made to make the loading and unloading of the artery easier. Female luer locks were epoxied to
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these endplates using silpoxy. Rubber stopper plugs were used to plug the fill/vent holes. Figure
12 shows the 3D printed endplates of the first design iteration.

Figure 12. First Design Iteration of Endplates.
Unfortunately, the finish of the PLA endplates was porous and allowed water to pass
through them. This became evident when the arm was put together with the sleeve and filled with
water for the first time. By this time, design changes were already evident in the endplates, so
they were redesigned and reprinted using a higher end fill and with ABS.
3.2.2 Skeleton Design Iteration 2
Several design changes were made for the second iteration of the surrogate arm skeleton.
The first of which was increasing the diameter of the center hole to 3/8in. Although this is slightly
larger than physiological conditions of a brachial artery, it is necessary in order to allow enough
flow into the artery during dynamic use to create a volume change in the surrogate arteries. The
next change was to use hose barbs instead of luer locks. Luer locks taper in the center and inhibit
adequate flow to enter the artery in each pulse. The next change was increasing the artery loading
hole from 1in diameter to 2in diameter. This change improved the ease of use when dealing with
putting the artery in the arm. The third change was switching one of the fill/vent holes with a
0.1in hole. Luer fittings and luer valves would be epoxied to the outside of hole in order to have a
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way to pressurize the arm once it is sealed. It was also necessary in order to attach a pressure
transducer for arm pressure measurement. A fourth design change was making the endplates a
uniform outer diameter of 4.25in. This was done because the molded sleeve was loose on the 4in
diameter and worked better when stretched. The ridge on the old design was not a necessary
feature, anyways. The second iteration of the endplates can be seen in Figure 13 and Figure 14.
The new endplates were 3D printed with ABS with a higher end fill as seen in Figure 15.

Figure 13. Second Iteration of Arm Endplates.

Figure 14. Second Iteration Arm Skeleton Design
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Figure 15. 3D Printed Endplates of Design Iteration 2
On the small hole of the fill endplate, seen on the right in Figure 15 above, 1/8in ID
tubing was epoxied on and a luer lock fitting and 3 way luer valve was attached to the outside
(Figure 16). A 1/2in expanding plug was used to plug and seal the fill hole. A layer of silicone
adhesive was applied to the outer diameter of the endplates. This created a compressible layer
between the sleeve and the surface of the endplates that was necessary in order to achieve an
airtight seal when the arm was at pressure.

Figure 16. Fill Endplate with Luer Valve
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This endplate design ended up not being completely airtight. By completing a dunk test
with the fabricated and sealed arm in water, it was discovered that the expanding plug was
leaking air.
3.2.3 Skeleton Design Iteration 3
The final design change was done in order to make the arm completely airtight. Instead of
having one endplate with a 1/2” fill hole, it would now have two small holes that 1/8” tubing and
luer lock fittings would connect to as seen in Figure 17. The final arm skeleton on the stand can
be seen in Figure 18

Figure 17. Endplate Design Iteration 3
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Figure 18. Arm Skeleton on Stand
3.3 Surrogate Arm Sleeves
The other component of the arm was the sleeve. Yong and Geddes in their surrogate arm
model used a sleeve made of Silastic. Silicone rubber was used instead of Silastic for this
surrogate arm model. Sleeves were made from both molded silicone and silicone rubber sheets. A
mold was created and used to create the molded sleeve. The next sleeve was made from stock
silicone rubber from McMaster Carr of 1/16in thickness. The flat sheet was epoxied into a sleeve
using silpoxy. The final sleeve was made of thin silicone food placemats found on Amazon.
These were epoxied with silpoxy the same way. All the sleeves can be seen in Figure 19.
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Figure 19. Sleeves Made for the Surrogate Arm. Molded Silicone (left), Sleeve made from
Silicone Placemat (middle), and Sleeve made from 1/16in thick Silicone Rubber (right).
Only the sleeve from the silicone placemat, seen in the middle of Figure 9, was used for
experimentation. The red silicone rubber sleeve, on the right of Figure 9, was unable to hold
pressure without leaking. Holes would form on the sleeve surface when the sleeve was
pressurized. At first, the holes were filled using silpoxy, but more holes ended up forming and it
was decided the material was not a viable option for the sleeve. The molded sleeve on the left was
very compliant and ballooned a lot when being used with the cuff. This sleeve was not used for
analysis due to it risking bursting when at high cuff pressures. Future design refinement of the
surrogate arm that inhibits any ballooning of the sleeve could allow for use of this sleeve.
3.4 Surrogate Arteries and Fabrication
Arteries were made from silicone rubber strips cut to length and glued at the edges. Thin
silicone rubber placemats were found on Amazon and used. The process was modified and had 3
different iterations that were improved each time. Improvements were done to create a better seal

28

of the artery. The first iteration of arteries were made with luer lock fittings. However, luer locks
were not used for the final design of the arm so the arteries had to be refabricated using hose
barbs. For each artery, 1.5in wide by 8.25in long strips were cut from the stock silicone rubber
sheets (Figure 20). Next, a paper strip was cut of known width and placed in the middle of one of
the cut-out strips (Figure 21). This width was recorded and varied between fabricated arteries to
act as a variable for changing compliance between arteries. Small pieces of double-sided tape
were used to prevent the paper strip from moving while the silpoxy was applied. An even coat of
silpoxy was then applied to the strip on the area not covered by the paper. The paper was then
removed, and the other strip was carefully placed on top. A textbook was then placed on top of
the strips in order to apply even pressure. The arteries were allowed 30 minutes to cure.

Figure 20. Silicone strips cut from stock material
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Figure 21. Measure paper strip placed over silicone strip
After the silpoxy cured and the strips were bonded together, the 1/4in ID fittings were
inserted. Two different fittings were used between all fabricated arteries that were called Fitting
A and Fitting B as seen in Figure 22. There was no benefit of one fitting over the other. For this
step, and to ensure a fully sealed artery, a small piece of 1/4in tubing was placed over side of the
fitting that would be inserted into the artery (Figure 23). After the fittings were inserted into the
arteries, they were adjusted so that the “tip to tip” length, or total length of artery and fittings, was
the right length for the proper fit in the surrogate arm. This length was determined through test
fitting the arteries in the arm and was found to be 9.75in for Fitting A and 9.625in for Fitting B.
the corner area around the fittings were cut as seen in Figure 24, and zip ties were used to create a
seal (Figure 25). Each artery was labeled with the size of the space in the center (width of paper
cutout). In total, 5 arteries were made and can be seen and described in Figure 26 and Table 1.
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Figure 22. Fitting A (left) and Fitting B (right) Used for Different Fabricated
Arteries. Both have an ID of 1/4in through.

Figure 23. Tubing Placed Over Fitting Before being Inserted into Bonded Silicone Strips

Figure 24. Artery with Fittings. Tip to tip length of 9.75in

31

Figure 25. Fully Fabricated Artery

Figure 26. Arteries Fabricated for use with the Surrogate Arm and Corresponding
Compliance Measurement Testing
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Table 1. Sizes of Arteries
Artery #

Center Width

Notes

1

1/3in

none

2

5/8in

Not sealed at edges. Could not be used

3

7/10in

Center space not uniform. Converted from artery initially
made using luer lock fittings. Not suitable for use
4

3/8in

none

5

1/2in

none

The reason for making multiple arteries was only to show that the artery fabrication
process could produce arteries with different compliances. Although multiple arteries were
fabricated, not all of them were used for all the experiments. Artery #2 did not fully seal on the
edges so data was unable to be collected for it. Artery #3, which was originally made with luer
locks, did not have a uniform seal, was unable to produce a reliable compliance curve in the first
round of artery compliance curve generation. As will be discussed in the compliance curve
generation section, the test was refined and repeated and artery #3 was not used with the refined
process. The refined compliance curve generation test was done only with arteries #1, #4, and #5.
The cuff compliance and static oscillometer test was only performed using artery #5.
3.5 Flow System
Prototype designs for a pulsatile flow system were developed, but they never moved past
the prototype stage due to the study not using a dynamic system. Plans for this system and
improvements to it are discussed in chapter 7.
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3.6 Model Setup
The surrogate arm was created in a way such that it can be put together and taken apart
easily each time it is used. The method of putting the arm together evolved over time and was
adjusted in order to achieve a fully sealed arm. These changes included the endplate / artery
interface and the method of clamping the sleeve on the endplates.
3.6.1 Model Setup Iteration 1
First, 1/4in ID x 3/8in OD tubing was fed through the center hole of the bottom endplate
(endplate without the fill hole). Next, one end of the artery was stuck into the tubing and the
tubing was pulled from the outside of the endplate. This caused the fitting and tubing to wedge in
the center hole of the endplate and create a plug effect that was watertight and prevented any
leaks while the arm was at pressure.
After the artery was placed, the sleeve was placed over the endplate. Then, a 4in diameter
by 1/4in wide rubber ring was placed over the portion of the sleeve that was on the endplate.
After this, a hose clamp was placed over the rubber ring and tightened using a Philips head
screwdriver, being careful to not let the rubber ring slip out from under the hose clamp. Using the
rubber ring was crucial to creating a sealed sleeve that the hose clamp could not achieve on its
own for the rubber ring helped direct the pressure to a narrower area. The other crucial step for
achieving a seal along the sleeve was coating the endplate edge with silicone as mentioned in
section 3.1.1.
Once the clamp was tightened, the internal supports were placed in the endplate and the
sleeve was back rolled partially to access the top portion of the supports. With the internal
supports sticking up, the fill endplate was placed, aligning the supports into position. Next tubing
was placed through the center hole of the top endplate and the artery was placed in it to form a
similar plug as on the bottom endplate. Once the artery was in position, the sleeve was rolled

34

back over the fill endplate and secured the same way using a rubber ring and a hose clamp. It was
important to make sure the hose clamps lined up for both the fill endplate and the bottom endplate
so that they did not get in the way when the arm got placed on the stand. The arm was then filled
through the fill hole with water. For this study, the arm was filled such that there was as little air
volume as possible in order to reduce the signals that might be lost from the air compressing
within the arm. Once full, the expanding plug was used to seal the hole by placing it in the hole.
The arm would be inflated with air to increase its pressure to ~30mmHg initially. This arm
iteration ended up not being airtight for two reasons and needed to be redesigned. The first of
which was already addressed and had to do with the expanding plug not being airtight and leading
to the endplates needing to be redesigned. The second reason was due to the artery/arm interface.
It was discovered that the tubing that connected to the arteries needed to be sealed to the arm to
prevent water from leaking when at high pressures.
3.6.2 Model Setup Iteration 2
The main changes for this set up included adhering the tubing that connected to the
arteries to the endplate and replacing the expanding plug. These were both done to prevent water
from leaking and depressurizing the arm. Along with adhering the tubing to the endplates, zip ties
were used to prevent water leaking from the arm into the arteries at the hose barb connection
Figure 27. The same hose clamp was used with a 1/4in wide rubber ring under it. Because the fill
hole was removed, the process for filling the arm changed. The sleeve was first secured and
clamped to one end of the arm. Then the arm was filled through the open end of the sleeve as
shown in Figure 28. Once filled, the other end of the sleeve was secured to the other end plate.
Once the arm was full, 12 inch clamps to prevent axial expansion of the arm while at high
pressure. This was an issue observed in the previous model setup. The full setup can be viewed in
Figure 29 and was used for round 1 of cuff compliance curve generation and oscillometric testing.
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Figure 27. Secured Artery and Endplate Interface

Figure 28. Filling the Surrogate Arm.
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Figure 29. Complete Surrogate Arm Model Iteration 2 Setup used for the First Set of
Oscillometric Data Testing
3.6.3 Model Setup Iteration 3
After the testing of the second model setup was complete, a third model setup iteration
was made and tested to reduce error from the oscillometric data. The error was hypothesized to be
from ballooning of the portion of the arm that was not covered by the sleeve. To prevent this in
the new model, a new clamp that reduced the effective compliant length of the arm was used. The
clamp used was a 4in pipe coupling with the rubber insert removed. The 1/4in wide rubber rings
were also removed and a portion of molded silicone rubber was placed around the endplates to
allow for uniform compression and seal of the endplate/sleeve/clamp interface. The model was
put together and filled using the same method as described in section 3.4.2 and the final model
can be seen below in Figure 30.
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Figure 30. Surrogate Arm System Iteration 3 used for the Second Set of Oscillometric Data
Testing
3.7 Experimental Methods Overview
Several steps needed to be taken to use the oscillometric model with the surrogate arm to
predict artery volume change using a blood pressure cuff. The first step involved generating
known artery compliance vs pressure curve relationships. The next step was to calibrate the blood
pressure cuff with the model and produce a cuff compliance curve. With the known cuff
compliance, the arm was tested in a static setup to assess the accuracy of the using both the artery
compliance curve and the cuff compliance curve to known artery volume changes.
3.8 Artery Compliance Curve Generation
Artery compliance curves were generated by measuring internal artery pressures at
known volume increments. Three different procedures were used to generate different compliance
curves of the arteries. The first two procedures were performed with the artery separate from the
surrogate arm system and the third procedure was done with the artery in the surrogate arm
system. The first procedure was performed on arteries #1, #3, #4, and #5. This was a preliminary
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procedure that was then refined and performed a second time in order to increase the correlation
of the compliance curves produced. The second procedure was only performed on arteries #1, #4,
and #5. Artery #3 was excluded because it was fabricated differently than the rest of the arteries
during early stages of manufacturing. This led to Artery #3 not having a uniform seal. It was only
used in the first test because it was only a preliminary test for refining the procedure.
A DELTRAN Disposable Pressure Transduce model DPT-100 from Utah Medical
products was used for experimentation. The pressure transducer was connected to a BIOPAC
MP160 and AqcKnowledge software for recording and processing the data.
3.8.1 Artery Compliance Curve Generation Round 1
The set up used for procedure 1 can be viewed in Figure 31. The set up consisted of a
10mL syringe connected to a luer valve on the proximal end of the artery, and a pressure
transducer on the distal end. The surrogate arm skeleton and stand were then used as a fixture to
hold the artery while performing the test.

Figure 31. Artery Compliance Measurement Setup
For the test, the artery was first filled with water and flushed of any air bubbles. Once the
artery was free of any air bubbles, the syringe was used to pull a vacuum in the artery. Some
water remained in the artery due to the rigid plastic fittings not being collapsible. Then, the luer
valve was closed and the syringe was removed and filled all the way to 10mL and replaced back
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onto the luer valve fitting (with the valve still closed). The AqcKnowledge data recording was
then started and ran continuously during the test. With the data recording, the luer valve was
opened and 1/2mL of water was injected into the artery and the valve was closed again. With the
valve closed, a marker was placed on the recording data by pressing the escape key. This process
of adding 1/2mL of water volume and creating a marker on the data was repeated until the artery
pressure exceeded 300mmHg. 300mmHg was selected because this was the effective pressure
limit of the Deltran pressure transducers used and is beyond physiological artery pressure range.
The data points were then manually inspected to determine artery volume vs pressure datasets
that were recorded in Microsoft EXCEL. This test was repeated 3 times for each artery.
3.8.2 Artery Compliance Curve Generation Round 2
The setup of the second procedure used was very similar to the first, but this time the
pressure transducer was connected to a 3-way luer valve on the proximal end shown in Figure 32.
This change was made because it was difficult to make a consistent vacuum measurement when
the pressure transducer was on the distal end due to the rigid fittings that did not collapse. The
other reason was because tube pressure measurements during dynamic surrogate arm use were
planned to also be made on the proximal end. The other change to this procedure was replacing
the 10mL syringe with a 3mL syringe in order to have more precise volume injections. 1/2mL
volume injections were still used. The procedure itself was nearly identical to the first. The first
step was to flush the artery with water to remove any air bubbles. The next step was to pull a
vacuum on the artery. Once the vacuum was pulled, the data recording was started and 1/2mL
injections were made and markers were placed after each injection. Once 3mL of total volume
was reached and the syringe was empty, the syringe was removed, filled, and reattached to the
luer valve. This was done without stopping data recording. This needed to be repeated at 6mL of
total artery volume. For data recording, rather than taking arbitrary values on the curves, the time
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averaged data values were recorded at each step to produce artery volume vs pressure datasets.
Figure 33 shows an example of data collection. These values were recorded in EXCEL. The test
was completed 6 times, rather than 3 times for the previous procedure, in order to increase the
amount of datapoints recorded.

Figure 32. Artery Compliance Curve Procedure 2 Setup

Figure 33. Sample Artery Compliance Data Acquisition
3.8.3 Artery Compliance Curve Generation Software Setup
A BIOPAC hardware system with AqcKnowledge software was used to measure and
record data. The transducer to hardware interface included the DELTRAN DPT-100 pressure
transducer connected to a TCI107 transducer module connected to a BIOPAC DA100C and a
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HLT100C differential amplifiers connected to the BIOPAC MP160 system. The hardware
connected to a laptop computer through USB connection which ran the AqcKnowledge software.
For the first set of artery compliance curve generation data collection, a single data
collection channel was used with gain set to 50, 10Hz low pass filter switched off, 300Hz low
pass filter switched on, and DC switched on for the DA100C. The amplifier was zeroed and
calibrated using a needle pressure gage to ensure accuracy.
For the second set of artery compliance curve generation, a slightly different software
setup was used. Due to some unknown issue with the MP160 and amplifier hardware, a large
amount of artefact signals were generated using a single data collection channel. Although the
root cause was not identified, a solution was found through setting up a “dummy” data collection
channel to create an open circuit before the active data collection channel. Eliminating the
artefacts on the data collection allowed for increased gain to be used on the amplifier to produce a
signal with more precision. A gain of 200 was used with 10Hz low pass filter switched off,
300Hz low pass filter switched on, and DC switched on again for the DA100C. The amplifier was
zeroed again and recalibrated with the new settings.
3.8.4 Artery Compliance Curve Data Analysis
Microsoft EXCEL was used to generate the artery compliance curves from the artery
𝑑𝑉

volume vs pressure datasets. Artery compliance (𝑑𝑃 ) was calculated using the difference quotient
𝑑𝑉

𝑉 −𝑉

at each point: 𝐶𝑜𝑚𝑝𝑙𝑖𝑎𝑛𝑐𝑒𝐴𝑟𝑡𝑒𝑟𝑦 = 𝑑𝑃 = 𝑃2 −𝑃1 . These values were then plotted vs the recorded
2

1

pressure at each step to produce a pressure (x) vs compliance (y) curve. The pressure vs
compliance plot was fit with a power function and 10% standard error bars were added. Pressure
below 5mmHg and the corresponding compliance values were excluded in the plot and curve fit
because they did not fit with the curve and were below the artery pressure region of interest.
3.9 Cuff System Calibration and Static Oscillometric Validation
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Cuff calibration was performed directly prior to taking data for the oscillometric model. It
involved creating a cuff compliance curve by measuring internal cuff pressures a known input air
volume increments. The air volume steps and the corresponding cuff pressures were recorded.
The procedure for the cuff calibration was refined after the first set of calibration and
oscillometric testing.
The static oscillometric model test was performed twice, once with the surrogate arm
iteration 2 and again with the surrogate arm iteration 3 so the cuff calibration step was
subsequently performed each time prior. The static oscillometric model test involved inflating the
cuff to around 100mmHg then inputting known water volume increments into the artery. The tube
pressures, arm pressures, and cuff pressures were recorded at each water volume injection. For
both sets of cuff calibration and oscillometric model data, artery #5 was used.
Round 1 of both the cuff calibration and oscillometric model tests were preliminary tests
to help establish protocol for the testing. Round 2 of both tests were more refined and controlled.
3.9.1 Cuff System Calibration Round 1
The setup for the first round of cuff calibration and oscillometric validation can be seen
in Figure 34. It was done using iteration 2 of the surrogate arm model. In the setup, one pressure
transducer was connected to the proximal end of the artery to measure the tube pressure, one
pressure transducer was connected to the arm to measure the arm pressure, and the third pressure
transducer was connected to the cuff to measure the cuff pressure. For this test, the arm was first
pressurized using a bulb pump to about 35mmHg. After the arm was pressurized, the cuff was put
onto the arm. The artery was then injected with an arbitrary amount of water volume. 6mL of
water was used for this test.
A100mL syringe was used to inject 30mL increments into the cuff for this test.
Beginning with an empty cuff, the data recording was started and the syringe was used to inject

43

30mL of air. The luer valve to the cuff was then closed and the syringe removed and filled back
to 30mL at ambient pressure. After exactly 10 seconds passed, the syringe was reattached and the
next volume injection was applied to the cuff. This process was repeated until the cuff reached
~180mmHg because the sleeve on the arm began ballooning significantly at high pressures.
After the first experiment, the arm pressure had dropped ~5mmHg in pressure and was
repressurized to ~35mmHg. This was repeated again after the second trial. Repressurizing the
arm between each dataset was observed to influence the cuff compliance curve generated.
Because of this, the data collection process was repeated 6 more times without repressurizing the
arm between trials for a total of 8 datasets. Only data from the last 6 datasets were used to
generate the cuff compliance curve. When collecting data, time averaged pressure for 5 seconds
starting at the peak of each pressure step. An example of data collection is shown in Figure 35

Figure 34. Setup of First Round of Cuff System Compliance and Static Oscillometric Model
Data
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Figure 35. Sample Cuff System Calibration Data Acquisition
3.9.2 Static Oscillometric Model Test Round 1
The first round taking data for the static oscillometric model was a trial run before being
refined for round 2 of testing. The test was completed directly after performing the cuff
compliance measurement. The same setup shown above in Figure 34 was used while making sure
to not adjust the position of the cuff or air and water volume in the arm. Any repositioning of the
cuff position or changes to the arm volume would result in a new cuff compliance relationship
than what was measured in the cuff calibration step.
The first step was to inflate the cuff to just above 100mmHg. Several minutes were
allowed to pass to allow the cuff pressure to settle because the pressure in the arm and cuff would
gradually decrease after air volume injection before leveling off after a few minutes. The greater
the cuff pressure, the greater this decrease was. After the pressure decay leveled off, the next step
was to flush the artery and pull a vacuum like how it was done for the artery compliance curve
generation procedure.
Once this was done, artery volumes were injected in two differed ways. The first method
was in 1mL volume increment steps. For this method, the tube pressure, arm pressure, and cuff
pressure were all measured at each volume step. The second method injected different volumes
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into the arteries ranging from 1mL to 7mL. The initial and final pressures in the tube, arm, and
cuff were measured for this test. Each test was only completed once.
The system pressure tended to gradually decrease in pressure over time. This decrease
prevented from holding the system pressure constant. This loss in pressure did not appear to be
because of an air leak. This decrease was accounted for by measuring the initial and the final
pressures of each measurement.
3.9.3 Cuff System Calibration Round 2
The setup for the second procedure used can be seen in Figure 36 and used iteration 3 of
the surrogate arm model. One key difference was that the cuff was put on the arm before
pressurizing the arm this time. After the cuff was placed over the arm, the arm was inflated to
50mmHg this time and allowed to rest for several minutes for the pressure to level off. Putting the
cuff on prior to inflating the arm led to the cuff bladder being more snug on the arm and made it
more sensitive to air volume input. Because of this, the volume steps for the cuff calibration were
done in 10mL increments using a 10mL syringe rather than 30mL increments using the 100mL
syringe. Volume was injected at ambient pressure. This allowed for increased precision for each
volume step. The 5 second time averaged pressure starting at the peak of each pressure step was
recorded.

Figure 36. Setup for Cuff System Calibration Test 2
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3.9.4 Static Oscillometric Model Test Round 2
The test was completed directly after performing the cuff compliance measurement
without any change to the setup. The cuff was not moved or adjusted, and the arm air and water
volume was not changed in order to not change the cuff compliance that was determined in the
previous test. Static oscillometric data was collected in two different ways again; incrementally
and in different sized volume steps.
For the incremental test, 1mL volume steps were used up to 9mL of total volume. The
data collection ran continuously during each test and the test was repeated 6 times. The tube, arm,
and cuff pressures were recorded at each volume step. Figure 37 shows example data of the
incremental static oscillometric test. The other method involved using 1mL, 2mL, 3mL, 4mL,
5mL, 6mL, 7mL, and 8mL volume injections. Starting with 1mL, the data recording was started,
and volume was injected, 5 seconds were allowed to pass, then the volume was removed. This
process was repeated 6 times. After all the injections were made for the 1mL volume, the data
recording was stopped. Figure 38 shows sample data collected for this test. This whole process
was repeated for each volume. The initial and final tube, arm, and cuff pressures were recorded
for each injection.

Figure 37. Sample Incremental Static Oscillometric Data Acquisition
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Figure 38. Sample Whole Step Static Oscillometric Data Acquisition
3.9.5 Cuff Calibration and Oscillometric Model Testing Software Setup
A BIOPAC hardware and AqcKnowledge software were used for collecting data. The
same pressure transducer to hardware interface as described in section 3.6.4. However, 3
DELTRAN DPT-100 pressure transducers, 3 TCI107 transducer modules and 3 BIOPAC
DA100Cs were used for this test.
6 channels were created for data collection, 3 of which were open channels and the other
three corresponded to the tube, arm, and cuff pressures. A gain of 1000 was used with 10Hz low
pass filter switched off, 300Hz low pass filter switched on, and DC switched on for each
DA100C. Each amplifier was zeroed and calibrated using a pressure bulb and pressure gage.
3.9.6 Cuff System Calibration Data Analysis
Cuff compliance curves were generated using the same analysis method for generating
artery compliance curves as described in section 3.6.5. Cuff compliance vs pressure curves were
fitted with polynomial fits.
3.9.7 Static Oscillometric Model Data Analysis
Data analysis was done on the static oscillometric measurements to show if a blood
pressure cuff was able to accurately measure volume change in the artery. This was done by using
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the cuff compliance curve generated in the cuff calibration step and the measured initial and final
pressures. The cuff compliance equation was found as a function of pressure, so compliance was
able to be calculated from the measured cuff pressures. This was done in three different ways
from each trial to produce 3 different sets of data: one using the initial cuff pressure, one using
the final cuff pressure, and one using the average cuff pressure. The next step was to calculate the
change in pressure which was simply Δ𝑃 = 𝑃𝑓𝑖𝑛𝑎𝑙 − 𝑃𝑖𝑛𝑖𝑡𝑖𝑎𝑙 . Finally, the volume change was
𝑑𝑉

found by multiplying the two results together: Δ𝑉𝑐𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝑑 = 𝑑𝑃 ∗ Δ𝑃. This volume change
calculated in the cuff was then assumed to reflect the volume change in the artery. Percent errors
were calculated using the known volume injection in the artery:
%𝑒𝑟𝑟𝑜𝑟ΔV =

Δ𝑉𝑎𝑐𝑡𝑢𝑎𝑙 −Δ𝑉𝑐𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝑑
Δ𝑉𝑎𝑐𝑡𝑢𝑎𝑙

∗ 100%. This was performed for both the incremental and the

whole step tests.
The other data analysis aspect of the static oscillometric model testing was predicting the
volume change in the artery using the change transmural pressure and the artery compliance
curve. Δ𝑉𝑐𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝑑 and %𝑒𝑟𝑟𝑜𝑟ΔV were found using the same calculation process for calculating
artery volume change using the cuff with the cuff pressure. The transmural artery pressure was
calculated as: 𝑃𝑡𝑟𝑎𝑛𝑠 = 𝑃𝑡𝑢𝑏𝑒 − 𝑃𝑎𝑟𝑚 . This was done using initial, final and average pressures.
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Chapter 4
RESULTS
4.1 Artery Compliance Round 1
Artery compliance curves varied in correlation. Artery 3 produced the least reliable curve
with a correlation of 0.7877. Each plot was fit to a power function. The curve for Artery 5 had the
highest correlation of 0.937. Figure 39 displays the curves generated for each artery. Raw
Acknowledge data from testing are found in Appendix A and data points collected for generating
the compliance curves are found in Appendix B.

Figure 39. Artery Compliance Curves from Round 1 of Testing. (A) Artery 1, (B) Artery 3,
(C), Artery 4, and (D) Artery 5
4.2 Artery Compliance Round 2
Round 2 of artery compliance measurement produced curves with increased correlations
around 0.95. Figure 40 displays the plots and compliance curves generated. Raw Acknowledge
data from testing are found in Appendix C and data points collected for generating the
compliance curves are found in Appendix D.
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Figure 40. Artery Compliance Curves from Round 2 of Testing. (A) Artery 1, (B) Artery 4,
and (C) Artery 5
4.3 Cuff System Compliance Round 1
Figure 41 shows the compliance curve produced for the cuff from the first round of
testing. Both a linear and 2nd degree polynomial were fit with correlations around 0.95. The 2nd
degree polynomial was used for calculation volume changes in the static oscillometric test. Raw
Acknowledge data from testing are found in Appendix E and data points collected for generating
the compliance curves are in Appendix F.
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Figure 41. Cuff System Compliance Curve from round 1 of Testing. The curve was fitted
with both a linear and a polynomial fit
4.4 Static Oscillometric Data Round 1
No significant results were found from both the incremental and whole step tests in the
first round of oscillometric testing. Raw AcqKnowledge data are found in Appendix G and
collected data used to calculate volume changes are found in Appendix H.
For the incremental test, high percent errors were observed from using the transmural
pressures and the cuff pressure to calculate volume change. initial, final, and average. Using
initial, final, or average pressure for the transmural artery pressure did appear to affect the
accuracy of the predicted artery volume change. Using the initial pressure was most accurate with
the lowest average percent error and using the final pressure was the least accurate with the
largest average percent error. These results are shown in Table 2.
Using initial, final, or average pressure for the cuff pressure did not appear to affect the
accuracy of the predicted artery volume change. The average percent error for each used pressure
for the cuff was around 26%. These results are shown in Table 3.
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Table 2 Round 1 Incremental Test Results Using Transmural Pressure

Table 3 Round 1 Incremental Test Results Using Cuff Pressure

53

For the whole step test, high percent errors were observed from using the transmural
pressures and the cuff pressure to calculate volume change. initial, final, and average. Using
initial, final, or average pressure for the transmural pressure did appear to affect the accuracy of
the predicted artery volume change. Using the initial pressure, on average, was least accurate with
the highest average percent error and using the final pressure was the most accurate with the
largest average percent error. These results are shown in Table 4.
Using the initial, final, or average pressure for the cuff pressure did appear to have some
effect on the accuracy of the predicted volume change. Using the initial pressure, on average, was
least accurate with the highest average percent error and using the final pressure was the most
accurate with the smallest average percent error. These results are shown in Table 5.
Table 4 Round 1 Whole Step Test Results Using Transmural Pressure
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Table 5 Round 1 Incremental Test Results Using Cuff Pressure

4.5 Cuff System Calibration Round 2
The second round of cuff system calibration produced the system compliance curve
found in Figure 42. The correlation of the curve produced and was only 0.898. Raw
AcqKnowledge data from testing can be found in Appendix I and data points collected for
generating the compliance curves can be found in Appendix J.
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Figure 42. Cuff System Compliance Curve from Round 2 of Testing
4.6 Static Oscillometric Data Round 2
Raw AqcKnowledge data can be found in Appendix K and collected data for calculating
volume changes can be found in Appendix L.
For the whole step test, using measured tube and arm pressures to calculate the predicted
artery volume change was unsuccessful as in Round 1. Using the initial transmural pressure to do
this was extremely inaccurate. Using the final transmural pressure and the average transmural
pressure were more accurate but still had a very high percent error. These results can be seen in
Table 6.
Changes in the cuff pressure were able to accurately measure volume changes in the
artery. Using the average pressure of the cuff to find the artery volume change was within 3.28%
for volume changes between 2mL and 8mL. Accuracy of measuring 1mL volume changes varied
up to 13.5 in error. Using the initial or final cuff pressures to calculate volume changes decreased
in accuracy as dV increased for 2mL to 8mL volume changes. These results are displayed in
Table 7.
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Table 6 Round 2 Whole Step Test Results Using Transmural Pressure

Table 7 Round 2 Whole Step Test Results Using Cuff Pressure
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The Round 2 incremental oscillometric test did not produce any significant results. Accuracy in
calcuating 1mL increments of volume change varied from less than 1% error to over 55% error.
This was consistent across all pressures used to calculate volume change from cuff pressure.
Table 8 Round 2 Incremental Test Results Using Cuff Pressure
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Chapter 5
DISCUSSION
5.1 Artery Compliance Measurement Refinement
The artery compliance procedure was refined to improve the quality of the curves
produced. The correlations of the curves increased to 0.95 as seen in Figure 41. Using the smaller
3mL syringe allowed for more precision in the volume. This decreased variability in pressure
measurements and most likely contributed to the improved correlation of the artery compliance
curve generated. Having better control of the initial artery pressure also most likely helped
improve the artery compliance curve correlations. This was an effect of moving the pressure
transducer from the distal end of the arm to the proximal end. Artefacts in the data on round 1
also made measured pressure less accurate which can be seen in Appendix A. The cause of these
artefacts was unknown, but they were able to be successfully removed by using an open circuit of
data collection in AqcKnowledge. Removing the artefacts for round 2 of testing then allowed for
a higher gain to be used on the hardware and increased the accuracy to measure pressures. This
was most likely the third reason that increased the correlation of the artery compliance curves.
Increasing the number of trials from 3 to 6 also increased the number of data points collected for
each curve. This could be another contributing reason for the increase in the curve correlations.
The compliance values showed the most variability at low pressure values. This is
because small differences in the first measured pressure have greater effect on the calculated
compliance than while at higher pressures. This led to the curves being less accurate at smaller
pressure values. This could be a reason why measuring 1mL increments in the oscillometric
testing was unsuccessful.
Recorded pressures during the test were also observed to decrease over time. The
pressure decrease appeared to reflect an decreasing power function. Measuring the artery
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compliance in increments results in the pressure to decay between increments. Because of this,
compliance curve testing and measurement is a time sensitive test and results might be affected
by the amount of time between volume injections.
5.2 Oscillometry Test Refinement and Accuracy
The first round of oscillometric testing was preliminary and done so to be able to refine
the system before completing a fully in-depth study. Using the refined testing process, the cuff
was able to accurately measure artery volume changes within 3.28% error for volume changes
between 2mL and 8mL (Table 7). This accuracy was found using the average pressure in the cuff
recorded during each volume step. The higher accuracy with the average pressure compared to
the initial or final pressure could be attributed to the increase of data points used for
calculationswith the average pressure. Removing the ballooning of the arm by using a new
clamps, less pressure was lost in the cuff, resulting in more accurate pressure measurements. The
bladder of the cuff did not completely cover the sleeve in the refined model setup and 1/2in of the
arm sleeve was still able to slightly balloon. Even so, the model was still able to measure artery
volume changes with the cuff. Using the average cuff pressure was the only consistently accurate
method for finding the volume change. Using the initial cuff pressure or the final cuff pressure
made the accuracy decrease as volume increased. 1mL increments were not able to be
consistently measured accurately.
Using the transmural artery pressure from the surrogate arm did not show accuracy for
finding the volume change in the artery. This could be evidence that there is error generated in the
arm system and results in a differing artery compliance in the system then what is measured in the
artery compliance test step. It might also be evidence that the error is dependent on the magnitude
of the volume change in the artery. Not being able to accurately predict volume using the
measured tube and arm pressures prevented the use of the model to predict artery volume changes

60

in a dynamic setting. Because of this, a dynamic test was not able to be performed on the cuff for
there would be no useful information that would be able to be obtained.
5.3 Stress Relaxation of Silicone
In all tests, it was observed that that measured pressures decayed after each volume step
injection. This decay appeared to follow an exponential decay function changes depending on the
spike pressure at each increment. Higher pressure spikes and larger pressure changes resulted in a
steeper rate of decay of pressure. This is proposed to be a result of the mechanical properties of
the silicone rubber that was used for the arteries and the surrogate arm cuff. This may have
affected the compliance curves generated for the arteries and resulted in the error of calculated
artery volume changes using the transmural pressure and artery compliance curves. When
injecting each step for the artery compliance curve generation, the elastic artery would relax, and
the pressure would decrease before the next volume was injected. This might have resulted in a
different pressure at higher volumes than if the total volume was injected at once. Developing an
artery compliance relationship using a whole step approach might produce a compliance curve
that more accurately reflect how the artery behaves. This might also have affected the compliance
curves for the cuff system, but it did not result in inaccurate measurement in artery volume
change with the cuff. This might be because the artery pressure is more sensitive to volume
changes compared to the cuff, therefore making it insignificant when calculating the volume
change using the cuff system compliance.
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Chapter 6
CONCLUSIONS
A blood pressure cuff was shown to accurately measure different artery volume changes
using a new surrogate arm model that was created for oscillometry. Volume changes were able to
be accurately measured using a blood pressure cuff within 3.28% of actual volume change by
using the average cuff pressure cuff and the calibrated cuff system compliance. This was
consistent for volume changes ranging from 2mL to 8mL. 1mL volume changes were not able to
be accurately measured and there was no consistency with the error of predicted volume changes.
The artery compliance procedure was refined to improve the quality of the curves
produced with correlations around 0.95. However, static oscillometric testing revealed that this
artery compliance curve was not accurate for calculating artery volume changes. This is a crucial
step that needs to be solved for the surrogate arm to be applicable to act as a bench top model for
blood pressure cuff devices. Without known volume change, there is no baseline to compare
accuracy of results during bench top testing.
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Chapter 7
FUTURE DIRECTIONS
7.1 Improvements to the Surrogate Arm
The first improvement to the arm would be to shorten the arm so that the arm sleeve is
completely covered by the cuff bladder. Even with the new clamp that was used, about 1/2in was
exposed that still partially ballooned when the cuff was pressured. The next design change could
be to change the interface between the internal supports and the endplates. Currently, the supports
are just placed in the endplates to provide support to prevent the arm from collapsing on itself.
However, they do not provide any supports for axial expansion. Because of this, clamps needed to
be used on the exterior of the arm. One idea would be to replace the three internal supports with a
single rod that screws into both endplates. A third change would be to create a new arm stand.
The stand used for the arm did not take into account the thickness of the sleeve and the hose
clamp, so the arm did not fit perfectly into the cutout of the stand. This did not appear to make a
difference for testing, so a new stand was not needed for this study. A new stand could be
designed that also acts as a fixture to account for axial expansion of the arm rather than
redesigning the internal support interface.
7.2 Accurate Measurement of Artery Volume Change Using Tube Pressure
The next and most crucial step is determining how to accurately measure artery volume
change using the transmural pressure. Error is most likely arising from the surrogate arm system.
A system needs to be developed to identify the source of error in the future.
Something that could be worth trying is changing the method of how artery compliances
are generated. For this study, the artery compliances were generated with an incremental
approach with 1mL steps. Instead, using a whole step approach might better reflect how the artery
compliance behaves when the artery experiences larger volume changes. For this test, an initial
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volume and pressure would be used then the pressure at injection volumes of 1mL, 2mL, 3mL,
4mL, 5mL, and so on. Volumes and pressures would be measured compliance curves would be
created.
Another possible method that could be worth trying is by performing the artery
compliance test while the artery is in the surrogate arm system and the recorded transmural
pressure. The artery compliance was measured outside of the pressurized arm system, but this
compliance relationship might be different than how the artery acts in the system. Creating a new
artery compliance with the artery in the arm could create a curve that more accurately represents
how the artery behaves in the system. This could be the first step to determining how error arises
from surrogate arm system when calculating artery compliance with measured transmural
pressure.
7.3 Dynamic Surrogate Arm System Testing
Once a method for reliably measuring artery volume change using tube pressure and
measured artery compliance relationships is developed, the arm can be used in a dynamic setting
with pulsatile flow. In order to do this, a flow system must be added to the surrogate arm system.
Dynamic testing of the surrogate arm would entail running the system for ~30 seconds and
measuring the flow waveforms and pressure waveforms in the cuff. A known artery volume
change could be measured using the flow waveform and compared to volume change found in the
cuff for accuracy and validation.
A pulsatile flow system was developed but not used for testing in this study. This system
was similar to the design presented by Yong and Geddes in their surrogate arm model. A
schematic of the system can be seen below in Figure 43. The system consists of a raised reservoir
standing 4 – 4.5ft tall to create the diastolic pressure (~100mmHg) on the proximal side of the
surrogate arm. The reservoir connects to 1/2in ID PVC piping. At the bottom of the PVC pipe,
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there is a corner joint that connects to 3/8in tubing and a 1-way check valve to prevent back flow
into the reservoir. Proximal to the arm is tubing that connects to a 100mL syringe. The syringe
acts as a diaphragm pump to the system to create pulsatile flow through the artery. Ideally, a
syringe pump could be used that would create repeatable pulses with uniform waveforms. A 3/8in
tee connector and 3/8in ID tubing then connects the syringe, reservoir, and surrogate arm. Distal
to the arm is a drain reservoir. A pump could be connected to this reservoir and used to feed the
drain water back to the diastolic reservoir in order to maintain a steady water level in the diastolic
reservoir during use.

Figure 43. Schematic of Flow System
7.4 Use of Surrogate Arm as a Bench Top Model Test
Once the a dynamic system test is successfully completed where dVcuff = dVartery, the
system will be valid to act as a bench top model test for oscillometric blood pressure cuff devices.
Different arteries are interchangeable on the system to create different measurable input artery
compliances in the system that can be detected with oscillometry.
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Appendix A: Artery Compliance Round 1 AcqKnowledge Data
Artery 1 Test 1

Artery 1 Test 2

71

Artery 1 Test 3

Artery 3 Test 1

72

Artery 3 Test 2

Artery 3 Test 3

73

Artery 4 Test 1

Artery 4 Test 2

74

Artery 4 Test 3

Artery 5 Test 1

75

Artery 5 Test 2

Artery 5 Test 3
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Appendix B: Artery Compliance Round 1 Data Tables
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80

81

82
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Appendix C: Artery Compliance Round 2 AcqKnowledge Data
Artery 1 Test 1

Artery 1 Test 2

84

Artery 1 Test 3

Artery 1 Test 4

85

Artery 1 Test 5

Artery 1 Test 6

86

Artery 4 Test 1

Artery 4 Test 2

87

Artery 4 Test 3

Artery 4 Test 4

88

Artery 4 Test 5

Artery 4 Test 6

89

Artery 5 Test 1

Artery 5 Test 2

90

Artery 5 Test 3

Artery 5 Test 4
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Artery 5 Test 5

Artery 5 Test 6
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Appendix D: Artery Compliance Round 2 Data Tables
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Appendix E: Cuff System Calibration Round 1 AcqKnowledge Data
Test 1

Test 2

100

Test 3

Test 4

101

Test 5

Test 6
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Appendix F: Cuff System Calibration Round 1 Data Table
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Appendix G: Static Oscillometric Testing Round 1 AcqKnowledge Data
Incremental Test

Whole Step Test
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Appendix H: Static Oscillometric Testing Round 1 Data Tables
Incremental Test

Whole Step Test
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Appendix I: Cuff System Calibration Round 2 AcqKnowledge Data
Test 1

Test 2

107

Test 3

Test 4

108

Test 5

Test 6
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Appendix J: Cuff System Calibration Round 2 Data Table
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Appendix K: Static Incremental Oscillometric Testing Round 2 AcqKnowledge Data
Incremental Test 1

Incremental Test 2

112

Incremental Test 3

Incremental Test 4

113

Incremental Test 5

Incremental Test 6
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Appendix L: Static Incremental Oscillometric Testing Round 2 Data Tables
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Appendix M: Static Whole Step Oscillometric Testing Round 2 AcqKnowledge Data
1mL Step

2mL Step

117

3mL Step

4mL Step

118

5mL Step

6 mL Step

119

7mL Step

8mL Step
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Appendix N: Static Whole Step Oscillometric Testing Round 2 Data Tables
Whole Ste Test
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